MEDTRONIC PUERTO RICO OPERATIONS CO. SURESCAN; STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF
|
Back to Search Results |
|
Model Number 97714 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Abscess (1690); Unspecified Infection (1930); Injury (2348)
|
Event Date 01/01/2018 |
Event Type
Injury
|
Manufacturer Narrative
|
Other applicable components are: product id: 977a260, serial# (b)(4), implanted: (b)(6) 2017, explanted: (b)(6) 2018, product type: lead.Product id: 977a260, serial# (b)(4), implanted: (b)(6) 2017, explanted: (b)(6) 2018, product type: lead.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a healthcare professional (hcp) via a manufacturer representative (rep) regarding a patient who was implanted with a neurostimulator.It was reported that there was a concern for infection because the patient had a wound and abscess near the midline spinal incision.The physician was concerned the wound might be tracking toward the spine.The wound was debrided, and the physician decided to remove the whole spinal cord stimulation (scs) system.There were no reports of device issues or allegations.The issues were resolved at the time of the report, the patient was alive with no injury, and there were no further complications reported or anticipated.
|
|
Manufacturer Narrative
|
Continuation of d11: product id 977a260 serial# (b)(6) implanted: (b)(6) 2017 product type lead product id 977a260 serial# (b)(6) implanted: (b)(6) 2017 product type lead.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received from the consumer and it was reported the patient had developed an infection somewhere around the area of the implantable neurostimulator (ins)/leads sometime in 2018.It was noted troubleshooting was performed, oral and iv antibiotics and entire spinal cord stimulator (scs) system was removed.The strain was unknown by the patient.No further complications were reported or anticipated.
|
|
Search Alerts/Recalls
|
|
|